Advocates, some AGs wary of Purdue Pharma bankruptcy plan
Some state attorneys general and opioid addiction activists pushed back Tuesday against a settlement offer from OxyContin maker Purdue Pharma, saying it didn't include enough money and goes too far in protecting the company and family members who own it from future liability.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
